Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere Health Condition 2: O989- Unspecified maternal infectious and parasitic disease complicating pregnancy, childbirth and the puerperium
Conditions
Interventions
None listed
Sponsors
Sparsh Hospital Foundation
Eligibility
Inclusion criteria
Inclusion criteria: All pregnant women who are infected with COVID 19 during the gestation period
Exclusion criteria
Exclusion criteria: NA
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. To study the rate of transmission of maternal COVID Ig G antibodies to the neonate. 2. To study the trend of maternally transmitted COVID Ig G antibodies in the neonate over the first seventy five days of life. Timepoint: first 75 days after the birth in a newborn. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1.To study the correlation of the COVID Ig G antibody levels to the duration since confirmed disease. 2. To study the correlation of the COVID Ig G levels to the severity of the covid disease. 3. To study the correlation of COVID Ig G levels to the duration since vaccination and the type of COVID vaccine used. 4. To study the correlation of COVID Ig G levels to the interval between vaccine doses. Timepoint: follow up time till 75 Days after the delivery | — |
Countries
India
Contacts
Public ContactJohn Paul
Sparsh super speciality Hospital
Outcome results
None listed